Should we be prepared to change the population composition of a species in order to wipe out a disease that is a terrible burden to mankind? During a well-attended working breakfast organised by the European Parliament’s Panel for the Future of Science and Technology (STOA) on 19 March 2019, experts and citizens delved into the case study of eradicating malaria by applying gene-drive technology. This genetic tool could enable us to suppress mosquito populations that transmit malaria by reducing the number of females. This would be done by introducing in some mosquitos a genetic mechanism that easily spreads – ‘drives’ – through the whole population over generations.
The purpose of the event was to gain insight into the science and ethics of gene-drive technology, and of genome-editing technologies in general. The meeting was chaired by Kay Swinburne, (ECR, UK) a STOA Panel member, who underlined the importance of invigorating public debate on such technologies in her opening statement. With more than 200 million cases of malaria each year worldwide, of which over 400 000 are fatal, no one doubts the importance of fighting this disease. This, as Kay Swinburne explained, makes the case less controversial than, for instance, human genome editing, and therefore it provides a good opportunity to focus on understanding the benefits of genetic technology. Such an understanding, combined with knowledge of the risks and concerns, and with awareness of different stakeholder perspectives, should help policy-makers anticipate the application of genome-editing technologies. With three expert presentations and a debate, this event provided input on all these fronts.
First, Jens Van Steerteghem, of KU Leuven, and a former STOA trainee, gave the audience a technical overview of gene-drive technology in the context of eradicating malaria. His presentation was based on a scientific briefing that was used in a preliminary foresight analysis project on gene drive and malaria. This project aimed to map the potential societal impact of gene-drive technology and exposed the need for a general risk assessment framework for biotechnological applications. Jens Steerteghem explained how the number of female mosquitos would be suppressed if the gene-drive method were applied: by introducing in males a gene on the Y chromosome that cuts their X chromosome, so that they only pass Y chromosomes to their offspring. This offspring are consequently exclusively male, and additionally carry the new gene on their Y chromosome.
Delphine Thizy, Stakeholder Engagement Manager with the non-profit research organisation Target Malaria delivered the second presentation. This organisation is developing the gene-drive technology method to reduce malaria. Delphine Thizy described the current state of the research at her organisation, commenting that only in September 2018, their team published a paper on a successful eradication experiment on a mosquito population in a containment cage. She also addressed some of the misconceptions and concerns she hears when explaining Target Malaria’s plans. These worries are expressed both by citizens in Western countries but also, and more importantly, from stakeholders in countries in sub-Saharan Africa that suffer from malaria. People question, for example, if the targeted mosquito species are crucial pollinators, or if the reduction of mosquitos would disturb food chains. For both cases, she indicated that there is no need to worry: the targeted mosquitoes are not known to be pollinators and just three mosquito species would be targeted out of 830 species in Africa alone.
NanoApps Medical, Inc. Aims To Develop Nanobiosensor for Malaria, Ebola, and Zika
News This Week
Cancer and AI – Can ChatGPT Be Trusted?
A study published in the Journal of The National Cancer Institute Cancer Spectrum delved into the increasing use of chatbots and artificial intelligence (AI) in providing cancer-related information. The researchers discovered that these digital resources accurately [...]
Breathing New Life: Oxygen Therapy Improves Heart Function in Long COVID Patients
A small trial has found that hyperbaric oxygen therapy (HBOT) may help restore proper heart function in patients with post-COVID syndrome, with participants in the HBOT group experiencing a significant increase in global longitudinal [...]
Wireless Brain-Spine Interface: A Leap Towards Reversing Paralysis
Summary: In a pioneering study, researchers designed a wireless brain-spine interface enabling a paralyzed man to walk naturally again. The ‘digital bridge’ comprises two electronic implants — one on the brain and another on the [...]
New study reveals a gel that promises to wipe out brain cancer for good
An anti-cancer gel promises to wipe out glioblastoma permanently, a feat that's never been accomplished by any drug or surgery. So what makes this gel so special? Scientists at Johns Hopkins University (JHU) have [...]
New production process for therapeutic nanovesicles
Particles known as extracellular vesicles play a vital role in communication between cells and in many cell functions. Released by cells into their environment, these “membrane particles” consist of a cellular membrane carrying a [...]
Could studying African killifish be the secret cure to sarcopenia?
The Australian Regenerative Medicine Institute (ARMI) at Monash University suggests that muscle wasting, known as sarcopenia, may be reversed in late-life The study utilized the African killifish as a model and found that muscles revert [...]
Virtual AI Radiologist: ChatGPT Passes Radiology Board Exam
The most recent version of ChatGPT, an AI chatbot developed for language interpretation and response generation, has successfully passed a radiology board-style exam, demonstrating both its potential and limitations, according to research studies published [...]
Harnessing Energy Waves: Smart Material Prototype Challenges Newton’s Laws of Motion
University of Missouri researchers designed a prototype of a small, lightweight active ‘metamaterial’ that can control the direction and intensity of energy waves. Professor Guoliang Huang of the University of Missouri has developed a [...]
Nanotechnology revolutionizes the way cancer-fighting T cells navigate and combat tumors
Vanderbilt researchers are bolstering the fight against cancer with technology that enhances the effectiveness of T cells that attack tumors. The cutting-edge research was recently published in the journal Science Immunology. Cancers co-opt both [...]
Molecular “Superpower” of Antibiotic-Resistant Bacteria Revealed in New Research
A species of ordinary gut bacteria that we all carry flourishes when the intestinal flora is knocked out by a course of antibiotics. Since the bacteria is naturally resistant to many antibiotics, it causes problems, particularly [...]
Human DNA Is All Over The Planet, And Scientists Are Worried
Every skin flake, hair follicle, eyelash, and spit drop cast from your body contains instructions written in a chemical code, one that is unique to you. According to a new study, technology has advanced [...]
Long COVID: The Invisible Consequence of Socioeconomic Inequality
A recent study conducted by the Universities of Southampton and Oxford reveals a strong correlation between the incidence of long COVID and the level of area-specific deprivation. It found that individuals from the most deprived regions are 46 [...]
Mutation Mystery: Unraveling the Secret Behind COVID-19’s Rapid Spread
Molecular modeling suggests structural consequences of an early protein mutation that promoted viral transmission. RIKEN researchers discovered that an early mutation (D614G) in the SARS-CoV-2 virus may have contributed to its rapid spread by altering the spike [...]
Protein nanoparticle vaccine with adjuvant improves immune response against influenza
A novel type of protein nanoparticle vaccine formulation containing influenza proteins and adjuvant to boost immune responses has provided complete protection against influenza viral challenges, according to a new study published by researchers in [...]
Decoding Long COVID: NIH Study Exposes the Inner Workings of Neurological Symptoms
A NIH study on twelve Long COVID patients found differences in immune cell profiles and autonomic dysfunction, contributing to the understanding of the condition and potentially leading to better diagnoses and new treatments. Twelve [...]
Pancreatic Cancer Vaccine Shows Promise in Small Trial
Using mRNA tailored to each patient’s tumor, the vaccine may have staved off the return of one of the deadliest forms of cancer in half of those who received it. Five years ago, a [...]
Leave A Comment